XAIR Beyond Air, Inc. Stock Quote

XAIR [NASD]

Index	-	P/E	-	EPS (ttm)	-1.21	Insider Own	8.10%	Shs Outstand	26.82M	Perf Week	3.40%
Market Cap	186.52M	Forward P/E	-	EPS next Y	-0.98	Insider Trans	1.74%	Shs Float	25.06M	Perf Month	1.58%
Income	-28.40M	PEG	-	EPS next Q	-0.27	Inst Own	18.40%	Short Float	5.16%	Perf Quarter	-13.99%
Sales	0.10M	P/S	1865.21	EPS this Y	28.60%	Inst Trans	0.41%	Short Ratio	3.76	Perf Half Y	-38.84%
Book/sh	3.17	P/B	1.82	EPS next Y	19.00%	ROA	-47.70%	Target Price	15.20	Perf Year	-18.01%
Cash/sh	2.59	P/C	2.23	EPS next 5Y	-	ROE	-59.90%	52W Range	4.78 - 16.41	Perf YTD	-38.77%
Dividend	-	P/FCF	-	EPS past 5Y	-13.90%	ROI	-62.40%	52W High	-64.78%	Beta	-0.52
Dividend %	-	Quick Ratio	15.30	Sales past 5Y	-	Gross Margin	-	52W Low	20.79%	ATR	0.56
Employees	45	Current Ratio	15.30	Sales Q/Q	-	Oper. Margin	-	RSI (14)	49.38	Volatility	13.91% 8.65%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	11.90%	Profit Margin	-	Rel Volume	11.12	Prev Close	6.27
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Jun 28 AMC	Payout	-	Avg Volume	343.86K	Price	5.78
Recom	1.60	SMA20	0.90%	SMA50	-2.53%	SMA200	-31.96%	Volume	3,813,484	Change	-7.81%

Apr-28-21

Initiated

Truist

Buy

$12

Oct-22-19

Initiated

Oppenheimer

Outperform

Jun-28-22 04:10PM	Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022 GlobeNewswire -7.81%
04:05PM	Beyond Airs LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure GlobeNewswire
Jun-14-22 04:30PM	Beyond Air® Announces Fiscal Year End 2022 Financial Results Conference Call and Webcast Moved to Tuesday, June 28th GlobeNewswire
Jun-01-22 07:00AM	Beyond Cancer Announces the Appointment of Jedidiah Monson, M.D. to Chief Medical Officer GlobeNewswire
May-17-22 04:05PM	Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022 GlobeNewswire +7.84%
07:00AM	Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer GlobeNewswire
May-16-22 07:05AM	Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast GlobeNewswire
May-06-22 06:29AM	Loss-Making Beyond Air, Inc. (NASDAQ:XAIR) Expected To Breakeven In The Medium-Term Simply Wall St.
Apr-25-22 04:05PM	Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022 GlobeNewswire +12.02%
07:00AM	Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022 GlobeNewswire
Apr-18-22 07:00AM	Beyond Air® to Participate in Three Upcoming Medical Conferences GlobeNewswire
Apr-11-22 07:00AM	Beyond Cancer Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect GlobeNewswire -7.95%
Mar-08-22 04:35PM	Beyond Cancer to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting GlobeNewswire
Feb-22-22 04:52AM	Beyond Air (NASDAQ:XAIR) Is In A Good Position To Deliver On Growth Plans Simply Wall St.
Feb-10-22 04:05PM	Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022 GlobeNewswire
Feb-08-22 08:00AM	Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022 GlobeNewswire
Feb-03-22 04:05PM	Beyond Air® Announces Two Appointments to Beyond Cancer Board of Directors GlobeNewswire
Jan-27-22 08:00AM	Beyond Air® Schedules Third Fiscal Quarter 2022 Financial Results Conference Call and Webcast GlobeNewswire -5.94%
Dec-14-21 09:15AM	Beyond Air Inc (XAIR) CEO and Chairman of the Board Steven A. Lisi Bought $341,200 of Shares GuruFocus.com +9.35%
Dec-10-21 09:14AM	Implied Volatility Surging for Beyond Air (XAIR) Stock Options Zacks
Dec-09-21 08:30AM	Beyond Air® Provides Regulatory Update for LungFit® PH GlobeNewswire -20.45%
05:56AM	Beyond Air Slides After LungFit Launch Delay Investing.com
Dec-01-21 08:00AM	Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer GlobeNewswire
Nov-18-21 04:05PM	Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer Private Placement GlobeNewswire -6.49%
Nov-11-21 04:05PM	Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2022 GlobeNewswire
Nov-04-21 03:01PM	Beyond Air, Inc. (XAIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks -9.44%
07:30AM	Beyond Air® Announces Formation of Beyond Cancer, a New Private Company Dedicated to Oncology Utilizing Ultra-High Concentration Nitric Oxide to Treat Solid Tumors GlobeNewswire
Nov-02-21 08:00AM	Beyond Air® to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference GlobeNewswire
Oct-25-21 08:00AM	Beyond Air® Schedules Second Fiscal Quarter 2022 Financial Results Conference Call and Webcast GlobeNewswire +5.37%
Oct-20-21 08:00AM	Beyond Air® Reports Positive Interim Results for LungFit® GO Pilot Study Using High Concentration Inhaled Nitric Oxide Self-Administered, At-Home for Nontuberculous Mycobacterial Lung Disease GlobeNewswire
Sep-21-21 04:30PM	Beyond Air® Provides Global Regulatory Update for LungFit® PH GlobeNewswire +6.91%
Sep-14-21 07:30AM	Beyond Air® to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit GlobeNewswire
Aug-25-21 03:55PM	3 Strong Buy Stocks Showing Monster Growth TipRanks +7.97%
Aug-20-21 04:15PM	Beyond Air® Announces CFO Transition GlobeNewswire -5.20%
Aug-10-21 04:05PM	Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2022 GlobeNewswire
Aug-03-21 03:00PM	Will Beyond Air, Inc. (XAIR) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-20-21 07:30AM	Beyond Air® Schedules First Fiscal Quarter 2022 Financial Results Conference Call and Webcast GlobeNewswire
Jul-14-21 07:51AM	Is Beyond Air (NASDAQ:XAIR) Using Debt Sensibly? Simply Wall St.
Jul-08-21 04:14PM	Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in July 2021 GlobeNewswire
Jun-23-21 07:49PM	3 Stocks Flashing Signs of Strong Insider Buying TipRanks
Jun-10-21 04:05PM	Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2021 GlobeNewswire
08:50AM	Thursdays Pre-Market: Heres What You Need to Know Before the Market Opens TipRanks
Jun-03-21 03:00PM	Will Beyond Air, Inc. (XAIR) Report Negative Earnings Next Week? What You Should Know Zacks -5.41%
May-26-21 07:30AM	Beyond Air® Reaches Settlement Agreement with Circassia for LungFit® PH GlobeNewswire
May-25-21 07:30AM	Beyond Air® Schedules Fiscal Year 2021 Financial Results Conference Call and Webcast GlobeNewswire
May-20-21 08:00AM	Beyond Air® Strengthens Commercial Leadership Team with Appointments of Head of Sales and Head of Marketing GlobeNewswire
May-13-21 08:00AM	Beyond Air® Presents Data in Hospitalized Patients with Viral Lung Infections (including COVID-19) from LungFit® PRO Programs at ATS 2021 GlobeNewswire
May-12-21 09:27AM	What Type Of Shareholders Make Up Beyond Air, Inc.'s (NASDAQ:XAIR) Share Registry? Simply Wall St.
May-03-21 08:00AM	Beyond Air® Appoints Peter Senior as Director of Business Development GlobeNewswire -6.03%
Apr-14-21 08:00AM	Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in May 2021 GlobeNewswire
Mar-24-21 08:00AM	Beyond Air® to Present Abstracts at the American Thoracic Society Virtual Sessions in May 2021 GlobeNewswire
Mar-01-21 08:00AM	Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in March 2021 GlobeNewswire
Feb-16-21 08:00AM	Beyond Air® Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease GlobeNewswire +7.35%
Feb-12-21 08:07AM	Does Beyond Air's (NASDAQ:XAIR) CEO Salary Compare Well With The Performance Of The Company? Simply Wall St.
Feb-09-21 04:05PM	Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business Update GlobeNewswire
02:30PM	Beyond Air, Inc. to Host Earnings Call ACCESSWIRE
Feb-02-21 12:31PM	Beyond Air, Inc. (XAIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jan-15-21 04:10PM	Beyond Air® Schedules Third Fiscal Quarter 2021 Financial Results Conference Call and Webcast GlobeNewswire
Jan-04-21 12:07AM	Steven Lisi Is The CEO & Chairman of the Board of Beyond Air, Inc. (NASDAQ:XAIR) And They Just Picked Up 4.3% More Shares Simply Wall St. +13.28%
Dec-07-20 08:00AM	Beyond Air® Initiates Patient Screening for LungFit GO Pilot Study for At-Home, Self-Administration of Inhaled Nitric Oxide in Nontuberculous Mycobacteria Lung Disease GlobeNewswire
Nov-27-20 02:53AM	Beyond Air (NASDAQ:XAIR) Has Debt But No Earnings; Should You Worry? Simply Wall St.
Nov-19-20 08:00AM	Beyond Air® to Participate in the 32nd Annual Piper Sandler Healthcare Conference from December 1-3, 2020 GlobeNewswire
Nov-11-20 04:10PM	Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2021 and Provides Business Update GlobeNewswire
02:30PM	Beyond Air, Inc. to Host Earnings Call ACCESSWIRE
07:30AM	Beyond Air® Submits Premarket Approval Application to FDA for LungFit PH to Treat Persistent Pulmonary Hypertension of the Newborn GlobeNewswire
Oct-23-20 08:00AM	Beyond Air® Schedules Second Fiscal Quarter 2021 Financial Results Conference Call and Webcast GlobeNewswire
Oct-21-20 07:00AM	Beyond Air® Approved to Initiate Clinical Study at 150 ppm Nitric Oxide with LungFit for the Treatment of Acute Viral Pneumonia Including COVID-19 GlobeNewswire
Oct-19-20 10:01AM	Beyond Air® Presents In Vivo Solid Tumor Data Confirming In Situ Cancer Vaccination with a Single Injection of Gaseous Nitric Oxide at the AACR Conference on Tumor Immunology and Immunotherapy GlobeNewswire
07:15AM	Beyond Air® Presents Data Showing Anti-Coronavirus Activity of Nitric Oxide at the CHEST Annual Meeting 2020 GlobeNewswire
07:00AM	Beyond Air® Presents Pilot Bronchiolitis Data at the CHEST Annual Meeting 2020 GlobeNewswire
Oct-16-20 08:00AM	Beyond Air® Presents Positive New Preclinical Data for the Use of a Single Injection of Gaseous Nitric Oxide as a Novel In situ Cancer Vaccination GlobeNewswire
Oct-13-20 12:33PM	Market Sentiment Around Loss-Making Beyond Air, Inc. (NASDAQ:XAIR) Simply Wall St.
Sep-30-20 08:00AM	Beyond Air® to Present Data on Nitric Oxide in the Treatment of Solid Tumors at the American Association for Cancer Research (AACR) Conference on Tumor Immunology and Immunotherapy GlobeNewswire
Sep-11-20 08:00AM	Beyond Air to Present at the Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech Summit GlobeNewswire
Sep-09-20 08:00AM	Beyond Air® to Present Posters on CoronaVirus and Bronchiolitis at the CHEST 2020 Annual Meeting GlobeNewswire
Aug-27-20 08:59AM	What Type Of Shareholders Own The Most Number of Beyond Air, Inc. (NASDAQ:XAIR) Shares? Simply Wall St. -10.00%
08:00AM	Beyond Air® to Present New Nitric Oxide Data in an e-Poster Presentation at the North America Conference on Lung Cancer 2020 (NACLC 2020) GlobeNewswire
Aug-10-20 04:01PM	Beyond Air Publishes New Data on Nitric Oxide to Treat M. Abscessus in the Peer-Reviewed Journal Access Microbiology GlobeNewswire
Aug-06-20 07:45AM	Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2021 and Provides Business Update GlobeNewswire -8.48%
Jul-23-20 08:00AM	Beyond Air® to Announce Fiscal First Quarter 2021 Financial Results on Thursday, August 6th GlobeNewswire
Jun-22-20 04:01PM	Beyond Air Reports Financial Results for Fiscal Fourth Quarter and Year-End 2020 GlobeNewswire
09:00AM	Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors GlobeNewswire
Jun-15-20 08:30AM	Beyond Air Announces First Patient Enrolled in its U.S. Study of Nitric Oxide Therapy Using the LungFit System in COVID-19 Patients GlobeNewswire +6.83%
08:00AM	Beyond Air Announces Publication of Peer-Reviewed Journal Article in Scientific Reports GlobeNewswire
Jun-08-20 05:30PM	Beyond Air Scheduled to Announce Fiscal Year 2020 Financial Results on Monday, June 22nd GlobeNewswire
Jun-03-20 09:25PM	Hedge Funds Are Warming Up To Beyond Air, Inc. (XAIR) Insider Monkey
May-26-20 08:30AM	Beyond Air Receives Approval from Health Canada to Study Nitric Oxide Generated and Delivered by the LungFit in COVID-19 Patients GlobeNewswire
May-20-20 08:30AM	Beyond Air Achieves Primary Endpoint in Pilot Bronchiolitis Study GlobeNewswire
May-15-20 08:30AM	Beyond Air to Present New Data in an e-Poster Presentation at the Upcoming AACR Virtual Annual Meeting II on June 22nd to 24th GlobeNewswire
08:25AM	Beyond Air Enters into New Common Stock Purchase Agreement Extending Relationship with Lincoln Park Capital GlobeNewswire
Apr-16-20 08:30AM	Beyond Air to Initiate Clinical Study Evaluating High Concentration Nitric Oxide for the Treatment of COVID-19 Patients in the United States GlobeNewswire -8.82%
Mar-18-20 08:30AM	Beyond Air Accelerates LungFit BRO COVID-19 Program GlobeNewswire -14.36%
Mar-16-20 08:00AM	Beyond Air Submits Investigational Device Exemption (IDE) to the United States Food and Drug Administration (FDA) for the Treatment of COVID-19 Patients GlobeNewswire +21.41%
Mar-05-20 09:00AM	Beyond Air Hosting Analyst Day Today, March 5, 2020 at 2:00 p.m. ET GlobeNewswire -14.82%
Feb-25-20 08:30AM	Beyond Air Hosting Analyst Day on March 5, 2020 GlobeNewswire -9.62%
Feb-07-20 08:30AM	Beyond Air Reports Financial Results for Fiscal Third Quarter 2020 GlobeNewswire
Jan-22-20 08:00AM	Beyond AirTM Schedules Third Fiscal Quarter 2020 Financial Results Conference Call and Webcast GlobeNewswire
Dec-22-19 07:43PM	Hedge Funds Have Never Been This Bullish On Beyond Air, Inc. (XAIR) Insider Monkey
Dec-18-19 04:03PM	Beyond Air Terminates Commercial Licensing Agreement for LungFit PH for Use in the Hospital Setting in the United States and China GlobeNewswire
Dec-12-19 04:15PM	Beyond Air, Inc. Announces Closing of $11.5 Million Public Offering and Private Placement of Common Stock and Exercise of Option to Purchase Additional Shares GlobeNewswire

Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Carey Robert	Director	Apr 05	Buy	6.71	20,000	134,200	567,323	Apr 06 04:15 PM
Carey Robert	Director	Mar 25	Buy	6.65	22,500	149,625	547,323	Mar 28 09:34 AM
Carey Robert	Director	Mar 24	Buy	6.58	3,685	24,247	524,823	Mar 28 09:34 AM
Carey Robert	Director	Mar 17	Buy	6.75	20,000	135,000	521,138	Mar 21 04:32 PM
Lisi Steven A.	CEO and Chairman of the Board	Jan 12	Option Exercise	3.66	83,334	305,002	1,233,445	Jan 14 08:30 AM
Lisi Steven A.	CEO and Chairman of the Board	Dec 29	Sale	9.53	21,376	203,756	1,150,111	Jan 03 04:15 PM
Carey Robert	Director	Dec 22	Buy	9.50	10,000	95,000	518,418	Dec 27 04:15 PM
Lisi Steven A.	CEO and Chairman of the Board	Dec 10	Buy	8.53	40,000	341,200	1,171,487	Dec 13 04:15 PM
Avniel Amir	COO and President	Dec 01	Sale	13.72	32,675	448,301	403,527	Dec 03 04:15 PM
BENTSUR RON	Director	Nov 24	Sale	13.53	37,464	507,071	182,436	Nov 26 05:19 PM
Avniel Amir	COO and President	Nov 23	Option Exercise	3.66	43,334	158,602	446,861	Nov 24 04:20 PM
Carey Robert	Director	Nov 23	Buy	12.35	5,000	61,750	508,418	Nov 26 05:16 PM
BENTSUR RON	Director	Nov 22	Option Exercise	3.66	50,000	183,000	232,436	Nov 24 04:15 PM
Carey Robert	Director	Nov 22	Buy	12.05	10,000	120,500	503,418	Nov 24 04:10 PM
Carey Robert	Director	Nov 19	Buy	14.10	12,000	169,200	493,418	Nov 23 04:50 PM
Lisi Steven A.	CEO and Chairman of the Board	Aug 13	Buy	7.85	25,000	196,250	1,031,487	Aug 17 04:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience